Ergoteles’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-26,662
| Closed | -$1.23M | – | 655 |
|
|
2023
Q2 | $1.23M | Sell |
26,662
-15,182
| -36% | -$700K | 0.06% | 407 |
|
|
2023
Q1 | $1.68M | Buy |
41,844
+18,162
| +77% | +$728K | 0.07% | 331 |
|
|
2022
Q4 | $1.1M | Sell |
23,682
-99,507
| -81% | -$4.61M | 0.04% | 441 |
|
|
2022
Q3 | $5.1M | Buy |
+123,189
| New | +$5.1M | 0.18% | 113 |
|
|
2022
Q2 | – | Sell |
-12,294
| Closed | -$893K | – | 1933 |
|
|
2022
Q1 | $893K | Sell |
12,294
-296
| -2% | -$21.5K | 0.03% | 472 |
|
|
2021
Q4 | $1.06M | Sell |
12,590
-115,510
| -90% | -$9.72M | 0.04% | 404 |
|
|
2021
Q3 | $11.6M | Sell |
128,100
-27,764
| -18% | -$2.5M | 0.42% | 56 |
|
|
2021
Q2 | $14.9M | Buy |
155,864
+146,264
| +1,524% | +$13.9M | 0.34% | 69 |
|
|
2021
Q1 | $1.09M | Buy |
+9,600
| New | +$1.09M | 0.03% | 354 |
|